Fraudulent Pfizer Trials

Die Welt, a mainstream media outlet in Germany, revealed that numerous subjects who suffered adverse events, including deaths, during Pfizer’s COVID-19 shot trials were removed from the trial data
 

A person known as “Pfizer subject C4591001 1162 11621327” died three days after receiving the second dose of Pfizer's COVID shot, reportedly due to stroke and arteriosclerosis; it was deemed unrelated to the shots
 

The CDC has since warned that people ages 65 and older who received Pfizer’s updated (bivalent) COVID-19 booster shot may be at increased risk of stroke 

Die Welt also revealed contradictions in Pfizer documents, adverse events from the shot downplayed and mass unblinding of study subjects, which wasn’t revealed in a later approval study
 

In November 2020, Pfizer claimed their COVID-19 shot was 95% effective against COVID-19, but this was highly misleading and based on flawed methodology, including excluding people who got COVID-19 within 14 days after their first shot
 

Pfizer has profited immensely despite the concerns, earning a record $100 billion in 2022, including $37.8 billion for its COVID-19 shots and $18.9 billion for its antiviral drug Paxlovid

Read the full analysis by Dr. Mercola
 

Subscribe to Mercola for more news & videos